TetraGraph® & TetraSens

TetraGraph® is a CE-marked, FDA approved, innovative and user-friendly digital system for monitoring patients under anesthesia in combination with NMBAs (neuromuscular blocking agents). TetraGraph® is intended to measure the effect of NMBAs simply and precisely, supporting clinicians in decision-making on the level of neuromuscular function in real time, and thus when it is safe to wake the patient after surgery. The system consists of a portable, handheld patient monitoring unit and disposable sensors.

By preventing complications and enabling care staff to follow guidelines and drug recommendations, TetraGraph® helps shorten hospitalizations and reduce the cost of health care. Senzime estimates the potential global market for TetraGraph® at 166,000 operating theaters, which perform 79 million procedures each year.